Why the study?
Guidelines recommend a heart team approach with shared decision-making for revascularization decisions in stable CAD, yet PCI remains prevalent.
Does the implementation of a heart team approach reduce the composite of death, myocardial infarction, or unplanned revascularization in patients with complex coronary artery disease?
Does the implementation of a heart team approach reduce the composite of death, myocardial infarction, or unplanned revascularization in patients with complex coronary artery disease?
Implementation of a heart team approach for complex coronary artery disease significantly increases appropriate CABG selection and is associated with a marked reduction in long-term adverse cardiovascular events.
Answers are grounded in this paper and cite their sources.
May support heart team use in complex CAD; leaves open confirmation in randomized trials.
BACKGROUND: In patients with stable coronary artery disease (CAD), treatment options include medical therapy, percutaneous coronary intervention (PCI), and coronary artery bypass grafting (CABG). The decision between PCI and CABG depends on disease severity and revascularization risk. Guidelines promote a heart team approach (HTA) with shared decision-making, yet PCI remains prevalent. METHODS AND RESULTS: We conducted a retrospective analysis of 753 patients with complex CAD (left main or multivessel disease and SYNTAX score ≥ 33) between January 2019 and April 2022. We evaluated a quality improvement program featuring a clinical decision flow map, a support system for risk score calculations, and a standard operating procedure for HTA. We compared HTA activation, revascularization strategy choices, and long-term cardiovascular outcomes (composite endpoint: death, myocardial infarction, or unplanned revascularization) between patients treated with HTA (HTA group, n = 448) and without HTA (non-HTA group, n = 304). The program significantly increased HTA activation (from 26.4% to 61.7%) and CABG selection (from 11.1% to 20.4%). The HTA group had better CABG recommendations and choices (75.5% vs. 37.2%, and 26.8% vs. 7.2%, respectively), with a lower incidence of the primary composite endpoint (18.1% vs. 42.4%). CONCLUSION: A quality improvement program enhances HTA activation and revascularization strategies, leading to improved cardiovascular outcomes in complex CAD patients.
No takes yet. Share an insight, caveat, or question.
Su et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: